Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
Holding OLMA?
Track your performance easily

Olema Pharmaceuticals (OLMA) Financial Statements

649 Followers

Olema Pharmaceuticals Financial Overview

Olema Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.063; its P/E ratio is -6.01; Olema Pharmaceuticals is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -30.38M$ -30.97M$ -30.42M$ -23.34M$ -20.09M
EBITDA$ -30.00M$ -30.59M$ -30.33M$ -23.25M$ -19.67M
Net Income Common Stockholders$ -30.38M$ -30.97M$ -26.77M$ -21.50M$ -20.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 239.10M$ 248.98M$ 261.81M$ 276.90M$ 167.44M
Total Assets$ 254.56M$ 263.69M$ 276.94M$ 292.80M$ 177.62M
Total Debt$ 1.96M$ 2.21M$ 2.42M$ 2.62M$ 2.01M
Net Debt$ -237.14M$ -246.77M$ -259.39M$ -274.28M$ -165.44M
Total Liabilities$ 27.39M$ 27.38M$ 23.05M$ 17.66M$ 16.04M
Stockholders Equity$ 227.16M$ 236.32M$ 253.90M$ 275.13M$ 161.58M
Cash Flow-
Free Cash Flow$ -27.56M$ -23.65M$ -18.48M$ -22.74M$ -22.12M
Operating Cash Flow$ -27.55M$ -23.50M$ -18.48M$ -22.74M$ -22.12M
Investing Cash Flow$ -4.88M$ -20.14M$ -30.91M$ -25.44M$ 14.11M
Financing Cash Flow$ 15.61M$ 8.82M$ 523.00K$ 130.63M$ 2.04M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History

Olema Pharmaceuticals Debt to Assets

Olema Pharmaceuticals Cash Flow

Olema Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis